Found 611 matching trials
Single Dose, Pharmacokinetic, Safety, Tolerability and QTc Study of GSK1278863 in Healthy Volunteers PHASE1 This study is being performed to comply with regulatory requirements that a...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Efficacy and Safety of TAK-438 for the Prevention of Recurrent Gastric or Duodenal Ulcers During Therapy of Low-dose Aspirin PHASE3 The purpose of this study is to evaluate the efficacy of TAK-438, once dail...
Show More Location
Multiple Locations
Learn More & Join Trial
Outcomes Of Perioperative Pregabalin On Total Knee Arthroplasty PHASE3 This study aims to provide high quality evidence from a double-blinded, ran...
Show More Location
Multiple Locations
Learn More & Join Trial
Evaluation of the Tolerability of Switching Subjects on Chronic ATC Opioid Therapy to Buprenorphine HCl Buccal Film PHASE2 The primary aim of this study is to determine if chronic pain subjects on a...
Show More Location
Vince and Associates Clinical Research, Inc.
Learn More & Join Trial
A Study to Assess the Safety, Tolerability, and Effects of MK-0974 (Telcagepant) on Exercise Tolerance in Patients With Stable Angina (MK-0974-014) PHASE1 This study will assess the safety of telcagepant in coronary artery disease...
Show More Location
Multiple Locations
Learn More & Join Trial
Effect of Probiotic on Gut Microbiome and Bacterial Translocation in Healthy Asian Volunteers PHASE4 Dysbiosis of the gut microbiome has been recognized to underlie the pathoge...
Show More Location
Changi General Hospital
Learn More & Join Trial
Pharmacological Treatment on the Recovery of Neurosensory Disturbance After Bilateral Sagittal Split Osteotomy PHASE2 The bilateral sagittal split osteotomy (BSSO) of the mandible is one of the...
Show More Location
Multiple Locations
Learn More & Join Trial
COVID-19 Outpatient Pragmatic Platform Study (COPPS) - Master Protocol PHASE2 The overall objective of this study is to efficiently evaluate the clinical...
Show More Location
ValleyCare Medical Center
Learn More & Join Trial
A Study of Response-Guided Duration of Combination Therapy With GS-9451, Pegasys® and Copegus® With and Without Tegobuvir (GS-9190) in Previously Untreated Subjects With Genotype 1 Chronic Hepatitis C PHASE2 This phase 2b study will evaluate the efficacy and safety of 16 and 24 week...
Show More Location
Digestive Health Specialists of the Southeast
Learn More & Join Trial
Disturbed Sleep Model Study. PHASE1 Subjects will be screened within 28 days. Each treatment session will consi...
Show More Location
GSK Investigational Site
Learn More & Join Trial